Search Results

Regulation of Protein Conformation Enables Cell-Selective Targeting of Virus-Mimicking Nanoparticles for siRNA Therapy of Glioblastoma.

• Authors : Zhu H; State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Centre for New Organic Matter, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Research Centre for Analytical Sciences, College of Chemistry, School of Medicine and Frontiers Science Center for Cell Responses, Nankai University, Tianjin, 300071, P. R. China.; Wang YF

• Source: Advanced materials (Deerfield Beach, Fla.) [Adv Mater] 2024 May 06, pp. e2401640. Date of Electronic Publication: 2024 May 06.Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 9885358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4095

Record details

Oncolytic viral therapy for gliomas: Advances in the mechanisms and approaches to delivery.

• Authors : Romanishin A; Institute of Medicine and Life Science, Immanuel Kant Baltic Federal University, Kaliningrad, 236041, Russia. Electronic address: .; Vasilev A

Subjects: Oncolytic Virotherapy*/Oncolytic Virotherapy*/Oncolytic Virotherapy*/methods ; Glioma*/Glioma*/Glioma*/therapy ; Oncolytic Viruses*/Oncolytic Viruses*/Oncolytic Viruses*/genetics

• Source: Virology [Virology] 2024 May; Vol. 593, pp. 110033. Date of Electronic Publication: 2024 Feb 20.Publisher: Academic Press Country of Publication: United States NLM ID: 0110674 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Dual-Responsive Nanorobot-Based Marsupial Robotic System for Intracranial Cross-Scale Targeting Drug Delivery.

• Authors : Wu J; State Key Laboratory of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences, Shenyang, 110016, China.; Institutes for Robotics and Intelligent Manufacturing, Chinese Academy of Sciences, Shenyang, 110016, China.

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy ; Robotic Surgical Procedures* ; Marsupialia*

• Source: Advanced materials (Deerfield Beach, Fla.) [Adv Mater] 2024 Mar; Vol. 36 (9), pp. e2306876. Date of Electronic Publication: 2023 Dec 14.Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 9885358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4095

Record details

MRI Detection and Therapeutic Enhancement of Ferumoxytol Internalization in Glioblastoma Cells.

• Authors : Petronek MS; Department of Radiation Oncology, University of Iowa, Iowa City, IA 52242, USA.; Teferi N

• Source: Nanomaterials (Basel, Switzerland) [Nanomaterials (Basel)] 2024 Jan 13; Vol. 14 (2). Date of Electronic Publication: 2024 Jan 13.Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101610216 Publication Model: Electronic Cited Medium: Print ISSN: 2079-4991

Record details

Pediatric Glioblastoma Multiforme: A Challenging Case of Rapid Growth and Clinical Deterioration in an 11-Year-Old Female Patient.

• Authors : I Kh Almadhoun MK; Medicine and Surgery, Mutah University, Karak, JOR.; Hattab AAW

• Source: Cureus [Cureus] 2023 Oct 26; Vol. 15 (10), pp. e47697. Date of Electronic Publication: 2023 Oct 26 (Print Publication: 2023).Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184

Record details

Pharmacological Akt and JNK Kinase Inhibitors 10-DEBC and SP600125 Potentiate Anti-Glioblastoma Effect of Menadione and Ascorbic Acid Combination in Human U251 Glioblastoma Cells.

• Authors : Despotović A; Department of Neurophysiology, Institute for Biological Research 'Siniša Stanković'-National Institute of the Republic of Serbia, University of Belgrade, Bulevar despota Stefana 142, 11000 Belgrade, Serbia.; Janjetović K

• Source: Biomedicines [Biomedicines] 2023 Sep 27; Vol. 11 (10). Date of Electronic Publication: 2023 Sep 27.Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059

Record details

Navigating the Immune Challenge in Glioblastoma: Exploring Immunotherapeutic Avenues for Overcoming Immune Suppression.

• Authors : Jain P; Internal Medicine, Maulana Azad Medical College, Delhi, IND.; Vashist S

• Source: Cureus [Cureus] 2023 Sep 27; Vol. 15 (9), pp. e46089. Date of Electronic Publication: 2023 Sep 27 (Print Publication: 2023).Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184

Record details

Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion.

• Authors : Sousa N; Institute of Developmental Biology & Neurobiology, Johannes Gutenberg University Mainz, Mainz, Germany.; Geiß C

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy ; Antineoplastic Agents*; Humans

• Source: BMC cancer [BMC Cancer] 2023 Aug 16; Vol. 23 (1), pp. 762. Date of Electronic Publication: 2023 Aug 16.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

In Situ Nitric Oxide Gas Nanogenerator Reprograms Glioma Immunosuppressive Microenvironment.

• Authors : Liu Y; State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Sciences and Medical Engineering, Southeast University, Nanjing, 210096, P. R. China.; Cui L

Subjects: Glioma*/Glioma*/Glioma*/metabolism ; Glioblastoma*/Glioblastoma*/Glioblastoma*/metabolism; Humans

• Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2023 Jun; Vol. 10 (18), pp. e2300679. Date of Electronic Publication: 2023 Apr 21.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

Record details

Clinicopathological and Immunohistochemistry Study of a Long Survivor of Giant Cell Glioblastoma in a Patient With Neurofibromatosis 1: Case Report.

• Authors : Al-Romaihi N; Pathology and Laboratory Medicine, Bahrain Defense Force Hospital Royal Medical Services, Riffa, BHR.; Awadh M

• Source: Cureus [Cureus] 2023 May 14; Vol. 15 (5), pp. e39014. Date of Electronic Publication: 2023 May 14 (Print Publication: 2023).Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184

Record details